Cargando…
Performance Evaluation of the New Chemiluminescence Immunoassay CL-1200i for HBV, HIV Panels
Infectious diseases such as HIV and HBV are a global concern for their impact in terms of public health and costs for national health services. A central role in contrasting the spread of the infections is represented by timely diagnosis. The speed of detection depends on several factors including t...
Autores principales: | Nicolai, Eleonora, Sarubbi, Serena, Pelagalli, Martina, Basile, Valerio, Terrinoni, Alessandro, Minieri, Marilena, Cennamo, Oreste, Grelli, Sandro, Bernardini, Sergio, Pieri, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296845/ https://www.ncbi.nlm.nih.gov/pubmed/37366871 http://dx.doi.org/10.3390/diseases11020083 |
Ejemplares similares
-
Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies
por: Pieri, Massimo, et al.
Publicado: (2022) -
Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
por: Cristiano, Antonio, et al.
Publicado: (2022) -
The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
por: Nicolai, Eleonora, et al.
Publicado: (2023) -
Comparison of Chemiluminescence Enzyme Immunoassay (Cl-ELISA) with Colorimetric Enzyme Immunoassay (Co-ELISA) for Imidacloprid Detection in Vegetables
por: Zhai, Rongqi, et al.
Publicado: (2023) -
Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution
por: Pieri, Massimo, et al.
Publicado: (2022)